188 results on '"Shamekhi, Jasmin"'
Search Results
2. A simply calculated nutritional index provides clinical implications in patients undergoing transcatheter aortic valve replacement
3. Autorinnen und Autoren
4. Herzerkrankungen und Schwangerschaft
5. Clinical and Hemodynamic Outcomes of Balloon-Expandable Mitral Valve-in-Valve Positioning and Asymmetric Deployment: The VIVID Registry
6. Left ventricular reverse remodeling after transcatheter aortic valve implantation in patients with low-flow low-gradient aortic stenosis
7. Mortality prediction of the frailty syndrome in patients with severe mitral regurgitation
8. Predictive value of the Fibrosis-4 index in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
9. Percutaneous trans-axilla transcatheter aortic valve replacement
10. Early response of right-ventricular function to percutaneous mitral valve repair
11. Left atrial function index (LAFI) and outcome in patients undergoing transcatheter aortic valve replacement
12. C-Reactive Protein to Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement
13. Spleen Size and Thrombocytopenia After Transcatheter Aortic Valve Implantation
14. Circulating chaperones in patients with aortic valve stenosis undergoing TAVR: impact of concomitant chronic kidney disease
15. Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry
16. Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
17. CT-derived Epicardial Adipose Tissue Inflammation Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
18. Impact of Coronary Artery Disease on Outcomes in Patients Undergoing Percutaneous Edge-to-Edge Repair
19. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR
20. Cholesterol Crystal Dissolution Rate of Serum Predicts Outcomes in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
21. Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement
22. Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis
23. Fractional flow reserve in patients with coronary artery disease undergoing TAVI: a prospective analysis
24. Transcatheter Aortic Valve Replacement Outcomes in Patients With Native vs Transplanted Kidneys: Data From an International Multicenter Registry
25. Impact of Hemodynamic Support on Outcome in Patients Undergoing High-Risk Percutaneous Coronary Intervention
26. Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis
27. Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications
28. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation
29. Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve Replacement
30. Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry
31. Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement
32. A simply calculated nutritional index provides clinical implications in patients undergoing transcatheter aortic valve replacement
33. Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR-A multicenter experience
34. Impact of different guidewires on the implantation depth using the largest self-expandable TAVI device
35. Echocardiographic Progression of Calcific Aortic Valve Disease in Patients with Preexisting Aortic Valve Sclerosis.
36. Impact of different guidewires on the implantation depth using the largest self-expandable TAVI device
37. Impact of new eGFR equations on risk assessment in patients undergoing transcatheter aortic valve implantation
38. Echocardiographic progression of calcific aortic valve disease in patients with preexisting aortic valve sclerosis
39. Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience
40. Mortality prediction of the frailty syndrome in patients with severe mitral regurgitation
41. Complete Revascularization in Patients Before Undergoing Transcatheter Aortic Valve Replacement: Desirable or Superfluous?
42. A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR—A multicenter analysis
43. Optimal Protamine-to-Heparin Dosing Ratio for the Prevention of Bleeding Complications in Patients Undergoing TAVR – A Multicenter Experience
44. Impact of Transradial Versus Transfemoral Artery Approach for Pre-Procedural Coronary Angiography on Outcomes in Patients Undergoing Subsequent TAVR
45. A staging classification of right heart remodelling for patients transcatheter-to mitral valve
46. Haemodynamic differences between two generations of a balloon-expandable transcatheter heart valve
47. A staging classification of right heart remodelling for patients undergoing transcatheter edge-to-edge mitral valve repair
48. Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement – A novel CT-based marker for the prediction of pulmonary hypertension and outcome
49. Haemodynamic differences between two generations of a balloon-expandable transcatheter heart valve
50. Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.